About
Male
Dr. Dave Messina has over 25 years of experience in healthcare and has been leading healthcare investments at Pioneer Fund since 2019. He has led 100+ deals including top portfolio companies like Gilgamesh ($1B exit to Abbvie) and Assort Health ($500M+ valuation). Previously he founded the RNA and machine learning company Cofactor Genomics (YC S15) and led it to national Medicare reimbursement. Dr. Messina also worked on the Human Genome Project.
Experience
Pioneer Fund
View →Senior Venture Partner · 2018 – present
SeedBusiness Development · Financial Services
YC S15Venture13St. Louis, MOHealth Care · Precision Medicine
Geneoscopy
View →Advisor
Growth63Saint Louis, Missouri, United StatesBiotech/Pharma · Biotechnology
Cofactor Genomics
View →COO · 2015 – present
YC S15Venture13St. Louis, MOHealth Care · Precision Medicine
Harmonix Fund
View →Advisor to Harmonix Fund I LP · 2020 – present
6La Quinta, California, United StatesVenture Capital
Cofactor Genomics
View →Chief Operating Officer · 2015 – present
YC S15Venture13St. Louis, MOHealth Care · Precision Medicine
Education
- Stockholm University · Ph.D, Computational Biology– 2012
- Washington University in St. Louis · MS, Genetics– 2004
- University of Illinois Chicago · B.S., Biology– 1996
Pioneer Fund Portfolio (3)
Octolane AI
Artificial Intelligence (AI)Seed5 emp
Argon AI, Inc.
HealthcareSeed2 emp
People at Pioneer Fund
Data from: yc, crunchbase
